Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

NCT01666730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acinar Cell Adenocarcinoma of the Pancreas
Duct Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: metformin hydrochloride
DRUG: oxaliplatin
DRUG: leucovorin calcium
DRUG: fluorouracil
OTHER: laboratory biomarker analysis

Sponsor

Case Comprehensive Cancer Center